|
No
|
NLK protein expression (%)
|
p
|
|---|
|
High
|
Low
|
|---|
|
Group
| | | | |
|
BPH
|
50
|
31 (62.0)
|
19 (38.0)
|
.003
|
|
PCa
|
118
|
44 (37.3)
|
74 (62.7)
| |
|
Age (year)
| | | | |
|
<70
|
45
|
14 (31.1)
|
31 (68.9)
|
.276
|
|
≥70
|
73
|
30 (41.1)
|
43 (58.9)
| |
|
Gleason score
| | | | |
|
4–6
|
42
|
28 (66.7)
|
14 (33.3)
|
<.001
|
|
7
|
20
|
7 (35.0)
|
13 (65.0)
| |
|
8–10
|
56
|
9 (16.1)
|
47 (83.9)
| |
|
CS (TNM)
| | | | |
|
T stage
| | | | |
|
T1-T2
|
56
|
28 (50.0)
|
28 (50.0)
|
.007
|
|
T3-T4
|
62
|
16 (25.8)
|
46 (74.2)
| |
|
N stage
| | | | |
|
N0
|
90
|
39 (43.3)
|
51 (56.7)
|
.015
|
|
N1
|
28
|
5 (17.9)
|
23 (82.1)
| |
|
M stage
| | | | |
|
M0
|
94
|
39 (41.5)
|
55 (58.5)
|
.065
|
|
M1 (bone)
|
24
|
5 (20.8)
|
19 (79.2)
| |
|
Nurr1 expression
| | | | |
|
High
|
84
|
18 (21.4)
|
66 (78.6)
|
<.001
|
|
Low
|
34
|
26 (76.5)
|
8 (23.5)
| |
- Statistical analyses were performed by the Pearson χ
2 test, p < 0.05 was considered significant
